US Oncology lnvestigational Products Center (IPC) — Irving, Texas

US Oncology lnvestigational Products Center (IPC) is a clinical research site located in Irving, Texas, United States 75063.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

US Oncology lnvestigational Products Center (IPC) has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Peripheral T-cell Lymphoma, Breast Cancer, Cervical Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Irving

Browse all research sites in Texas · View every site in Irving

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology lnvestigational Products Center (IPC)?

US Oncology lnvestigational Products Center (IPC) has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology lnvestigational Products Center (IPC) conducted?

US Oncology lnvestigational Products Center (IPC) has 6 clinical trials on record, with 2 currently active. Their work covers Peripheral T-cell Lymphoma, Breast Cancer, Cervical Cancer.

Is US Oncology lnvestigational Products Center (IPC) accredited by Crixeo Clinical Trials?

US Oncology lnvestigational Products Center (IPC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology lnvestigational Products Center (IPC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.